Correction: Host Factors and Biomarkers Associated with Poor Outcomes in Adults with Invasive Pneumococcal Disease.

There is an error in the Table 3. Within the column labeled “OR (95% CI)”, the values are incorrect for the row labeled “Non-vaccine serotypes”. The correct values are: 1.5 (0.8–3.0). Please see the corrected Table 3 here.

Table 3

Risk factors associated with mortality within 28 days among patients with invasive pneumococcal disease by multivariate logistic regression analysis.

Characteristic	Survived (n = 384)	Died (n = 122)	Multivariate analysis e	p value f
	n (%)	n (%)	OR (95% CI)
Age groups
<50 y	45 (11.7)	5 (4.1)	1	-
50–64 y	87 (22.7)	18 (14.8)	1.6 (0.5–5.6)	NS
65–79 y	155 (40.4)	51 (41.8)	3.0 (0.9–9.6)	NS
≥80 y	97 (25.3)	48 (39.3)	6.5 (2.0–21.6)	.002
Underlying disease
Liver diseasea	33 (8.6)	17 (13.9)	3.5 (1.6–7.8)	.002
Lung diseaseb	34 (8.9)	4 (3.3)	0.4 (0.1–1.4)	NS
Mechanical ventilation	52 (13.5)	40 (32.8)	3.0 (1.7–5.6)	< .001
Laboratory findings c
WBC (<4.0×103 cells/μL)	39 (10.2)	41 (33.6)	6.9 (3.7–12.8)	< .001
Cr (≥2.0 mg/dL)	46 (12.1)	44 (36.4)	4.5 (2.5–8.1)	< .001
LDH (≥300 IU/L)	118 (32.1)	61 (53.0)	2.4 (1.4–4.0)	.001
Serotype d
PCV7 serotypes	139 (36.2)	44 (36.1)	1	-
PCV13 and PPSV23 serotypes	182 (47.4)	50 (41.0)	0.8 (0.5–1.5)	NS
Non-vaccine serotypes	60 (15.6)	20 (23.0)	1.5 (0.8–3.0)	NS

a Includes chronic hepatitis or cirrhosis that was secondary to alcohol abuse or viral infection.

b Includes chronic obstructive pulmonary disease, bronchial asthma, interstitial lung disease, and bronchiectasis.

c Laboratory findings; WBC, white blood cell count; Cr, creatinine; LDH, lactate dehydrogenase.

d Serotype; PCV7, 7-valent pneumococcal conjugate vaccine; PCV13, 13-valent pneumococcal conjugate vaccine; PPSV23, 23-valent pneumococcal polysaccharide vaccine.

e Multivariate analysis; OR, odds ratio; CI, confidence interval.

f NS, not significant (p ≥ .05).